Seamlessly engage with biotech teams, external medicinal chemists, biologists, and other internal and external partners to develop workflows that generate optimal screening collections, high-quality models, and testable ligand-design hypotheses, strengthening the ability of Biotech/ExploR&D collaboration teams to deliver differentiated hits and leads. Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women's Initiative for Leading at Lilly (WILL).